EDWARDS LIFESCIENCES CORPORATION Funds and ETFs Edwards Lifesciences Corporation
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 88.14 USD | +0.52% |
|
+1.44% | +15.59% |
ETFs positioned on Edwards Lifesciences Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.46% | 43 M€ | -0.13% | - | |
| 2.34% | 21 M€ | +8.41% | - | |
| 1.17% | 222 M€ | +4.30% | - | |
| 1.17% | 24 M€ | 0.00% | - | |
| 1.17% | 26 M€ | +0.30% | - | |
| 1.11% | 15 M€ | -3.61% | ||
| 1.06% | 2 M€ | +9.08% | ||
| 0.97% | 1 M€ | +2.21% | - | |
| 0.94% | 4,592 M€ | -.--% | ||
| 0.89% | 38 M€ | -.--% | ||
| 0.73% | 9 M€ | -.--% | - | |
| 0.52% | 1 M€ | +16.32% | ||
| 0.46% | 2 M€ | +20.44% | - | |
| 0.44% | 5 M€ | -72.95% | - | |
| 0.42% | 3,859 M€ | +18.82% | - | |
| 0.42% | 469 M€ | -2.05% | ||
| 0.36% | 7 M€ | +5.01% | ||
| 0.36% | 2,334 M€ | +16.24% | ||
| 0.34% | 36 M€ | +22.19% | ||
| 0.33% | 55 M€ | +11.84% | ||
| 0.33% | 26 M€ | +4.20% | - | |
| 0.30% | 749 M€ | +8.64% | ||
| 0.30% | 219 M€ | +17.17% | - | |
| 0.30% | 1,448 M€ | -.--% | - | |
| 0.25% | 261 M€ | -.--% | - | |
| 0.24% | 200 M€ | +11.96% | - | |
| 0.24% | 488 M€ | +14.46% | ||
| 0.24% | 330 M€ | -.--% | - | |
| 0.23% | 2 M€ | +14.69% | - | |
| 0.23% | 9 M€ | +7.98% | - | |
| 0.23% | 825 M€ | +10.15% | ||
| 0.21% | 276 M€ | +11.40% | - | |
| 0.21% | 26 M€ | +23.61% | - |
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Calendar
2024-07-24
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
88.14
USD
Average target price
96.31
USD
Spread / Average Target
+9.27%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +15.59% | 53.11B | |
| +9.48% | 222B | |
| +13.72% | 195B | |
| +23.79% | 148B | |
| +33.39% | 113B | |
| +4.75% | 66.45B | |
| +3.16% | 50.03B | |
| -4.35% | 38.8B | |
| -1.27% | 34.85B | |
| +22.61% | 30.98B |
- Stock Market
- Equities
- EW Stock
- Funds and ETFs Edwards Lifesciences Corporation
